Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Europa Stream

 

AI scribe company Heidi enters SE Asia

Australia-based healthcare AI scribe provider Heidi has opened a new regional headquarters in Singapore, marking its entry into the Southeast Asian market. The move follows a $65 million USD Series B funding round led by Point72 Private Investments, a US-based hedge fund.

UK private dentistry could face CMA review over price transparency

UK Chancellor Rachel Reeves has called on the Competition and Markets Authority (CMA), the principal competition regulator in the UK, to launch an investigation into the country’s private dentistry sector, citing concerns over “hidden costs, lack of transparency and overtreatment.”  Letters released by the government reveal that Reeves has asked the regulator to examine how effectively competition operates among private providers and whether patients receive genuine choice and value for money.

Increasing demand for GLP-1 drugs driving supply chain consolidation by big pharma

GLP-1s are no longer regarded as “breakthrough treatments"; they are now seen as routine treatments for the management of chronic conditions. The rising demand for GLP-1s has also created pressure on supply chains, prompting increased investment in manufacturing and distribution, and vertical integration by major pharmaceutical companies — something that was highlighted by many speakers at the Jefferies London Healthcare Conference this week. 

HBI’s Digital Health Special Report 2025

HBI's first ever Special Report on digital health features analysis and commentary from various experts on the current state of play in digital health, and where the market might be headed, as well as in depth case study interviews with eight different digital health companies, each showcasing a different aspect to healthcare's digital revolution: HealthHero, Kry/Livi, Arts en Zorg, Health Navigator (HN), Helfie AI, Clue, Hellobetter and Flow Neuroscience.

Siemens mulls reducing Healthineers stake to minority, Siemens Healthineers continues to mull diagnostics unit sale

German multinational medtech firm Siemens Healthineers is reviewing strategic options for its diagnostics division, including a possible sale. The company stated that its laboratory unit, which supplies a range of technologies to diagnostic labs including equipment and reagents, is being developed under several scenarios and may no longer be the best fit within the group.

Circio looking for partners to help bring circular RNA gene therapy technology to market

Circio, a pre-clinical biotech company that is listed on the Oslo stock exchange, has developed a form of RNA technology that, if successful, could make cell and gene therapy much safer, more effective and more economic, and therefore available to a wide population. HBI sat down with Lubor Gaal, the company’s CFO, at Jefferies’ Global Healthcare Conference in London this week, to understand a bit more about the technology and what the company needs to get to market.

Kooth continues US expansion with Kismet acquisition

UK-based listed digital mental healthcare group Kooth is continuing its expansion into the US market with the acquisition of Kismet, a small US digital mental healthcare company that specialises in under 12s. Kooth’s CEO Kate Newhouse tells us the acquisition will expand the capabilities and reach of Kooth’s US platform Soluna.

Find Us